Abstract
Diagnosis of transplant dysfunction usually requires kidney biopsy. Sidgel etal. compared urinary proteomics with matched kidney biopsies to develop a biomarker panel to differentiate acute rejection, BK viral nephropathy, and chronic allograft nephropathy. The results suggest that monitoring a panel of urinary peptides may ultimately facilitate noninvasive diagnosis and management of common transplant complications.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have